The Impact of Lymph Node Dissection on High Risk Versus Low Risk Endometrial Cancer

C. Zhang,A. Soochit,J. H. Liu

DOI: https://doi.org/10.1093/annonc/mdy285.161

IF: 51.769

2018-01-01

Annals of Oncology

Abstract:Background: The aim of this study is to determine the benefits of lymph node dissection (LND) and the pattern of recurrence in low and high risk endometrial cancer (EC) patients. Methods: EC patients who underwent surgery as primary treatment between April 2003 to March 2012 was identified and stratified into low-risk and high-risk groups for lymph node metastasis (LNM) according to these criteria: poor differentiation, non-endometrioid histology, deep myometrial invasion, cervical stromal involvement, adnexal involvement, tumor diameter ≥ 3cm, suspicious node in imaging. Univariate survival analysis followed by Cox-regression model for multivariate analysis was used to find prognostic factors for survival. The χ2 and Fisher’s exact test were used to compare categorical valuables. Results: A total of 847 patients were included, among whom 524 received LND. After stratification 579 patients were assigned to high-risk group while 268 patients were assigned to low-risk group. LND was performed in 451 high-risk patients and in 73 low-risk patients with a rate of positive nodes of 14.1% (n = 64) and 2.7% (n = 2), respectively. Poor differentiation, non-endometrioid histology, deep myometrial invasion and adnexal involvement were independent prognostic factors. Whereas LNM was an independent prognostic factor for overall survival (OS, p = 0.03) but not for progression-free survival (PFS, p = 0.07). LND did not improve PFS (p = 0.56) or OS (p = 0.47) in the low-risk group and was not associated with OS (p = 0.17) in high-risk group. In 89 patients who had recurrence, 73 (13.9%) occurred in those with LND and 16 (5.0%) in those without LND. In high-risk group no significant difference was noted in recurrence rate (LND 16.0% vs without LND 8.6%, p = 0.06). Distant organs (lung, liver, bone, spleen and brain) and distant lymph nodes were the most common site of recurrence in both patients who underwent (5.9%, n = 31) LND and those who did not undergo (3.4%, n = 11) LND (p = 0.14). Conclusions: According to our findings LND seemed not to have survival benefit for both high-risk and low-risk patients based on the above criteria, and it could not decrease risk of distance recurrence. A more reliable stratification model should be considered to determine the benefit of LND in EC. Legal entity responsible for the study: Sun Yet-sen University Cancer Center. Funding: Has not received any funding. Disclosure: All authors have declared no conflicts of interest.